Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Defining Survival: FDA's New Requirements for Oncology Trial Design | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Summary by targetedonc.com
FDA's new guidance clarifies overall survival data collection in clinical trials, emphasizing long-term follow-up, subgroup analysis, and trial design considerations.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

targetedonc.comtargetedonc.com

Defining Survival: FDA's New Requirements for Oncology Trial Design | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA's new guidance clarifies overall survival data collection in clinical trials, emphasizing long-term follow-up, subgroup analysis, and trial design considerations.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

targetedonc.com broke the news in on Monday, October 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

FDA icon

FDA

Rockville, Maryland icon

Rockville, Maryland

News
For You
SearchBlindspotLocal